BSE NSE
Your Result on : Company News
Zydus Lifesciences Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
532321
ISIN Demat
INE010B01027
Book Value (Rs)
145.1076344
NSE Symbol
ZYDUSLIFE
Divident Yield %
0.63
Market Cap
(Rs In Cr.)
95,954
P/E (TTM)
35.7
EPS (TTM)
26.71
Face Value
(Rs)
1
Date Heading
26-Apr-24 Zydus Lifesciences Ltd - Zydus Lifesciences Limited - Press Release
25-Apr-24 Zydus Lifesciences Ltd - Zydus Lifesciences Limited - Updates
24-Apr-24 Zydus Lifesciences' injectable manufacturing site concludes USFDA insp
24-Apr-24 Sensex up 203 pts, oil & gas shares advance
24-Apr-24 Zydus Life declines after US FDA concludes manufacturing facility insp
24-Apr-24 Zydus Lifesciences Ltd - Zydus Lifesciences Limited - Updates
24-Apr-24 Zydus Lifesciences Ltd - Zydus Lifesciences Limited - Updates
23-Apr-24 Zydus announces NDA acceptance of Desidustat in China by NMPA
23-Apr-24 Zydus Lifesciences Ltd - Zydus Lifesciences Limited - Other General Pu
22-Apr-24 Zydus launches Mirabegron ER Tablets in US market
22-Apr-24 Zydus Life edges higher after launching OAB treatment drug Mirabegron
22-Apr-24 Nifty above 22,200 level; PSU bank shares advance
22-Apr-24 Indices trade higher; consumer durable shares rally
22-Apr-24 Zydus Lifesciences Ltd - Zydus Lifesciences Limited - Press Release
20-Apr-24 Sentynl receives marketing authorisation for NULIBRY® from UK MHRA
Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)